A novel report of apoptosis in human lung carcinoma cells using selective agonist of D2-like dopamine receptors: A new approach for the treatment of human non-small cell lung cancer

International Journal of Immunopathology and Pharmacology

Volumn 26, Issue 2, 2013, Pages 393-402

  Sheikhpour, M ^a,b   Ahangari, G ^b   Sadeghizadeh, M ^a   Deezagi, A ^b  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b NATIONAL INSTITUTE OF GENETIC ENGINEERING AND BIOTECHNOLOGY   (Iran)

Author keywords

Apoptosis; Bromocriptine; Human lung cancer cells; Non small cell lung cancer

Indexed keywords

BROMOCRIPTINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; LIPOCORTIN 5; AGAROSE; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL DEATH; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DNA CLEAVAGE; DNA FRAGMENTATION; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; CARCINOMA CELL; CELL DIFFERENTIATION; FETUS; FLUORESCENCE MICROSCOPY; MTT ASSAY; NON SMALL CELL LUNG CANCER; RNA EXTRACTION;

EID: 84881249753     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201302600212     Document Type: Article

References (30)

1. Brenner DR, Boffetta P, Duell EJ, et al. Previous lung diseases and lung cancer risk: a pooled analysis from the international lung cancer consortium. Am J Epidemiol 2012; 176:573-85.
2. Cote ML, Liu M, Bonassi S, et al. Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium. Eur J Cancer 2012; 48:1957-68.
3. Risch A, Plass C. Lung cancer epigenetics and genetics. Int J Cancer 2008; 123:1-7. (Pubitemid 351705185)
4. Peng YH, Zhang JM, Zhou NK, Wang S. Expression of dopamine receptor D2 in pulmonary carcinoma cells and effects of dopamine on the cell apoptosis. Nan Fang Yi Ke Da Xue Xue Bao 2011; 31:975-78.
5. Entschladen F, Lang K, Drell TL, Joseph J, Zaenker KS. Neurotransmitters are regulators for the migration of tumor cells and leukocytes. Cancer Immunol Immunother 2002; 51:467-82.
6. Senogles SE. D2 dopamine receptor-mediated antiproliferation in a small cell lung cancer cell line, NCI-H69. Anticancer Drugs 2007; 18:801-7. (Pubitemid 46975966)
7. Campa D, Zienolddiny S, Lind H, et al. Polymorphisms of dopamine receptor/transporter genes and risk of non-small cell lung cancer. Lung Cancer 2007; 56:17-23. (Pubitemid 46356636)
8. Wu X, Hudmon KS, Detry MA, Chamberlain RM, Spitz MR. D2 dopamine receptor gene polymorphisms among African-Americans and Mexican-Americans: a lung cancer case-control study. Cancer Epidemiol Biomarkers Prev 2000; 9:1021-26.
9. Arvigo M, Gatto F, Ruscica M, et al. Somatostatin and dopamine receptor interaction in prostate and lung cancer cell lines. J Endocrinol 2010; 207:309-17.
10. Salvador A, Dubreuil D, Denouel J, Millerioux L. Sensitive method for the quantitative determination of bromocriptine in human plasma by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2005; 820:237-42. (Pubitemid 40724590)
11. de Leeuw van Weenen JE, Parlevliet ET, Maechler P, et al. The dopamine receptor D2 agonist bromocriptine inhibits glucose-stimulated insulin secretion by direct activation of the alpha2-adrenergic receptors in beta cells. Biochem Pharmacol 2010; 79:1827-36.
12. de Leeuw van Weenen JE, Auvinen HE, Parlevliet ET, et al. Blocking dopamine D2 receptors by haloperidol curtails the beneficial impact of calorie restriction on the metabolic phenotype of high-fat diet induced obese mice. J Neuroendocrinol 2011; 23:158-67.
13. Yin D, Kondo S, Takeuchi J, Morimura T. Induction of apoptosis in murine ACTH-secreting pituitary adenoma cells by bromocriptine. FEBS Lett 1994; 339:73-5. (Pubitemid 24086654)
14. Attari F, Sepehri H, Delphi L, Goliaei B. Apoptotic and necrotic effects of pectic acid on rat pituitary GH3/B6 tumor cells. Iran Biomed J 2009; 13:229-36.
15. Trouillas J, Chevallier P, Remy C, et al. Differential actions of the dopamine agonist bromocriptine on growth of SMtTW tumors exhibiting a prolactin and/or a somatotroph cell phenotype: relation to dopamine D2 receptor expression. Endocrinology 1999; 140:13-21. (Pubitemid 29011135)
16. Shaikhpoor M, Ahanghari G, Sadeghizadeh M, Khosravi A. Significant changes in D2-like dopamine gene receptors expression associated with non-small-cell lung cancer: could it be of potential use in the design of future therapeutic strategies? Curr Cancer Ther Rev 2012; 8:304-308.
17. Stockert JC, Blazquez-Castro A, Canete M, Horobin RW, Villanueva A. MTT assay for cell viability: Intracellular localization of the formazan product is in lipid droplets. Acta Histochem 2012; 114:785-96.
18. Ahangari G, Halapi E, Tehrani MJ, Fransson J, Ham mar H, Wigzell H. RT-PCR topography of chronic psoriasis skin based on analysis of T-cell receptor B variable region gene usage. Scand J Immunol 1997; 45:534-40. (Pubitemid 27198716)
19. Shariati GR, Ahangari G, Hossein-nezhad A, Asadi SM, Pooyafard F, Ahmadkhaniha HR. Expression changes of serotonin receptor gene subtype 5HT3a in peripheral blood mononuclear cells from schizophrenic patients treated with haloperidol and Olanzapin. Iran J Allergy Asthma Immunol 2009; 8:135-9.
20. Ostadali MR, Ahangari G, Eslami MB, et al. The detection of dopamine gene receptors (DRD1-DRD5) expression on human peripheral blood lymphocytes by Real time PCR. Iran J Allergy Asthma Immunol 2004; 3:169-74.
21. Fadok VA, Savill JS, Haslett C, et al. Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. J Immunol 1992; 149:4029-35. (Pubitemid 23068888)
22. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 1995; 184:39-51.
23. Yin D, Kondo S, Takeuchi J, Morimura T, Vaux D. Bcl-2 gene prevents apoptosis in murine acth-secreting adenoma cells induced by bromocriptine. Int J Oncol 1994;4:187-91. (Pubitemid 24012581)
24. Yin D, Kondo S, Takeuchi J, Morimura T. Induction of apoptosis in rat somatotrophin-secreting pituitary adenoma cells by bromocriptine. Oncol Res 1993; 5:383-7. (Pubitemid 24145950)
25. Deng J. Effect of dopamine and bromocriptine on secretion of growth hormone by pituitary growth hormone secreting tumor in cell culture. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 1990; 12:3303-4.
26. Woldman I, Reither H, Kattinger A, Hornykiewicz O and Pifl C. Dopamine inhibits Cell growth and cell cycle by blocking ribonucleotide reductase. Neuropharmacology 2005; 48:525-37. (Pubitemid 40332410)
27. Wasko R, Wolun-Cholewa M, Bolko P, Kotwicka M. Effect of bromocriptine on cell apoptosis and proliferation in GH3 cell culture. Neuro Endocrinol Lett 2004; 25:223-28. (Pubitemid 39145016)
28. Pisick E, Skarin AT, Salgia R. Recent advances in the molecular biology, diagnosis and novel therapies for various small blue cell tumors. Anticancer Res 2003; 23:3379-96. (Pubitemid 36975439)
29. Pisick E, Jagadeesh S, Salgia R. Small cell lung cancer: from molecular biology to novel therapeutics. J Exp Ther Oncol 2003; 3:305-18. (Pubitemid 38056109)
30. Passon N, Puppin C, Lavarone E, et al. Cyclic AMP-response element modulator inhibits the promoter activity of the sodium iodide symporter gene in thyroid cancer cells. Thyroid 2012; 22:487-93.